Mounjaro and Coughing: Separating the Myth from What the Evidence Says

The misconception worth correcting: Mounjaro doesn't target your airways

When a new symptom appears shortly after starting a medicine, it's natural to connect the two. With tirzepatide, that instinct often misfires when it comes to coughing. Mounjaro works as a dual GIP and GLP-1 receptor agonist, meaning it acts on gut-hormone pathways involved in appetite and blood-sugar regulation. It slows gastric emptying and reduces hunger signals, none of which involves the bronchial tubes or upper respiratory tract. The NHS patient information for tirzepatide lists the well-known side effects clearly, and cough does not feature among them. Randomised trial data from the SURMOUNT-1 programme (involving thousands of adults across 72 weeks) did not identify cough as a notable adverse event.

That does not mean every person who develops a cough while on Mounjaro is imagining a connection. It means the mechanism isn't direct. Something else is usually doing the work.

Reflux is the most likely explanation when a cough does appear

Tirzepatide slows the rate at which the stomach empties. For most people this is part of why it reduces appetite so effectively. But slower gastric emptying can also mean stomach contents sit higher for longer, making acid reflux (and the dry, irritating cough that often accompanies it) more likely. This is sometimes called a reflux cough or laryngopharyngeal reflux, and it is common enough in the general population that many people already had a degree of reflux before starting treatment. Mounjaro can tip a borderline situation into a noticeable one.

If your cough is worse after eating, at night, or when lying flat, and you also have heartburn or a slightly bitter taste in the mouth, reflux is the most plausible explanation. Your GP or prescriber can advise on whether an antacid or dietary adjustment helps. Eating smaller portions (something many people find easier on tirzepatide anyway) can reduce reflux symptoms too. This is also a good moment to review what Mounjaro is and how it works, because understanding the gastric-emptying mechanism often makes sense of these secondary effects.

Other causes that have nothing to do with your injection

Tirzepatide is a weekly injection. Most new coughs are not weekly medicines, they are viral infections, seasonal allergies, post-nasal drip, or the lingering effects of a cold, all of which are far more common than any drug-induced cough. It is also worth noting that some people start Mounjaro in autumn or winter, exactly when respiratory viruses are circulating. Timing creates a false association.

ACE inhibitor blood pressure medicines (ramipril, lisinopril and others) are a well-known cause of a dry persistent cough in a meaningful minority of people who take them. If you are on one of these alongside Mounjaro, your prescriber may want to consider whether the ACE inhibitor is the culprit. Checking your full medication list with a prescriber before attributing anything to tirzepatide is straightforward, and is exactly the kind of conversation that happens at a Mounjaro consultation. You can also read about the broader landscape of tirzepatide as a treatment if you want the fuller clinical picture before you speak to anyone.

When a cough on Mounjaro needs prompt attention

Reassurance is useful, but it has limits. A few situations mean you should seek medical help without delay rather than waiting to see whether symptoms settle. If your cough comes with shortness of breath, chest tightness or pain, high fever, or you are coughing up blood or unusual amounts of mucus, contact your GP or call 111. These are not tirzepatide effects, they are symptoms that need clinical assessment in their own right.

The January 2026 MHRA Drug Safety Update on GLP-1 medicines focused on pancreatitis rather than respiratory effects, but it serves as a reminder that any new or unusual symptom while on a GLP-1 medicine deserves a clinical ear. Severe stomach pain that radiates to the back is the pancreatitis warning sign to know; a cough alone is not. Patients can report any suspected adverse reaction, however uncertain, through the MHRA's Yellow Card scheme.

Some people also notice other unexplained physical sensations when they start tirzepatide. Leg discomfort, for example, is another query that comes up, what that typically involves is covered separately. Skin reactions are another area worth being informed about: itching on Mounjaro is occasionally reported at injection sites and elsewhere, and the pattern is different again from respiratory symptoms such as a Mounjaro cough.

If you're considering treatment and want to discuss any personal health history (including a tendency to reflux or an existing respiratory condition) our prescribers review every consultation individually, on the same day it is submitted. A real clinician reads your answers; no algorithm makes that call. Speak to our prescribers to start that conversation.